• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Brexit - Articles and news items


Looking for life sciences opportunities in a post-Brexit world

Blog, Z Homepage promo / 13 February 2017 / Dr Penny Owen, Life Sciences Hub Wales

From government regulation to European trade, Life Sciences Hub Wales chairperson, Dr Penny Owen, looks ahead to the unknown of a post-Brexit world…

Wickham Labs logo

Wickham Labs to Exhibit at Pharmig 2016

Supplier news / 3 November 2016 / Wickham Laboratories Limited

Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th…

Opening life sciences’ Unified Patent Court war chest

Blog, Z Homepage promo / 11 October 2016 / Vanessa Rieu and Annsley Merelle Ward

Vanessa Rieu and Annsley Merelle Ward explain how life sciences companies can leverage their knowledge of national patent laws in a post-Brexit Europe…

GlobalData on the difficulties and opportunities of Brexit for pharma

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

While a Brexit undoubtedly creates significant issues for the UK pharma industry, opportunities remain for the sector to thrive, according to GlobalData…

GlobalData discuss the consequences of the EU referendum

Industry news / 23 June 2016 / Victoria White, Digital Content Producer

The company says for the healthcare industry to thrive in the event of the UK leaving the EU, the country would need to adopt a uniquely British approach…

EU Referendum: Tell us what you think…

Blog / 20 June 2016 / Caroline Richards, Editor, European Pharmaceutical Review

With only days to go until Britain holds a referendum on its EU membership, we can’t help but wonder how you feel…

Leaving EU could be a setback for Life Sciences in the UK

Blog / 8 June 2016 / Dr Alexander Moscho, Bayer UK & Ireland CEO

In this opinion piece, Dr Alexander Moscho, Bayer UK & Ireland CEO, says a vote to leave the EU will deter investment and make it harder for patients to access new medicines…

UK life sciences are stronger in the EU, says BioIndustry Association

Blog, Z Homepage promo / 16 March 2016 / Steve Bates, BioIndustry Association (BIA) Chief Executive

Here, Steve Bates, Chief Executive of the BioIndustry Association (BIA), makes a case for the UK remaining in the EU from the perspective of the life sciences sector…

UK pharma businesses should start assessing the Brexit effect, says Hogan Lovells

Industry news / 13 May 2015 / Victoria White

Businesses, including those in the pharmaceutical sector, should start assessing the potential consequences of a Brexit, advises Hogan Lovells…